Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-02

Clinical Trial Update: Effect of N-803 on B Cell Follicles in Antiretroviral Treated HIV Disease [Phase 1]

View source ↗

Summary

Phase 1 trial examining the effect of N-803 on B cell follicles in antiretroviral-treated HIV disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-803

Snippet

Sponsor: University of Minnesota | Conditions: Hiv, HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2024-04-02